Publications by authors named "Kay Brinkmann"

Claim this Profile
U
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and mutation.
Susana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, Alberto Hernández-Barranco, Pilar Ximénez-Embún, Kay Brinkmann

J Exp Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and mutation.
Susana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, Alberto Hernández-Barranco, Pilar Ximénez-Embún, Kay Brinkmann

J Exp Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.
Barbara Bathke, Juliane Pätzold, Ronny Kassub, Raphael Giessel, Kerstin Lämmermann, Kay Brinkmann

Immunology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin.
Stephanie L Sanos, Ronny Kassub, Marco Testori, Marlene Geiger, Juliane Pätzold, Kay Brinkmann

Front Immunol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.
Michael Wolferstätter, Marc Schweneker, Michaela Späth, Susanne Lukassen, Marieken Klingenberg, Kay Brinkmann

J Virol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.
Sonia T Wennier, Kay Brinkmann, Charlotte Steinhäußer, Nicole Mayländer, Claudia Mnich

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity.
Henning Lauterbach, Juliane Pätzold, Ronny Kassub, Barbara Bathke, Kay Brinkmann

Front Immunol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence.
Marc Schweneker, Susanne Lukassen, Michaela Späth, Michael Wolferstätter, Eveline Babel, Kay Brinkmann

J Virol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.
Ryan B Rountree, Stefanie J Mandl, James M Nachtwey, Katie Dalpozzo, Lisa Do, Kay Brinkmann

Cancer Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.
Karen Baur, Kay Brinkmann, Marc Schweneker, Juliane Pätzold, Christine Meisinger-Henschel

J Virol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vector systems for heterologous expression of proteins in Saccharomyces cerevisiae.
Martin Funk, Rainer Niedenthal, Dominik Mumberg, Kay Brinkmann, Volker Rönicke

Methods Enzymol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis